Treatment Management and Factors Affecting Mortality in Retroperitoneal Hemorrhage Due to Cardiac Catheterization; Single Center Experience

Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital

Status: Completed

Conditions: Mortality; Treatment Procedure

Treatments: Procedure: Retroperitoneal hematoma due to cardiac catheterization

Study type: Observational

Funder types: Other

Identifiers

NCT03006120

2016.5/7-18

Details and patient eligibility

About

Bleeding complications after cardiac catheterization have been reviewed previously, but there are very few studies on retroperitoneal hematoma and appropriate treatment of patients is not well defined. For this reason, the investigators aimed to analyze the clinical manifestations of retroperitoneal hematomas in a single center using a case-control study design, to analyze the treatment procedure determinants and consequently to provide an updated and usable treatment algorithm.

Enrollment: 68 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Retroperitoneal hematoma following cardiac catheterization

Exclusion criteria

• Patients with retroperitoneal hematomas other than cardiac catheterization and patients with missing file records.

Trial design

68 participants in 3 patient groups

Group 1

Description:

Conservative management

Treatment:

Procedure: Retroperitoneal hematoma due to cardiac catheterization

Group 2

Description:

Angiografic stenting

Treatment:

Procedure: Retroperitoneal hematoma due to cardiac catheterization

Group 3

Description:

Surgery

Treatment:

Procedure: Retroperitoneal hematoma due to cardiac catheterization